Discussion 1
Some of the factors that can interfere with compliance in regimens designed to decrease hyperglycaemia and in turn improve health outcomes for diabetics include: disease- and treatment-related, health care provider and medical system, psychological, and demographic factors (Delamater, 2006). Chronic conditions, for example, have been related with lower regimen adherence. Simpler regimens have also been shown to reflect better adherence for medications for diabetic patents. Moreover, social support from health care givers has been associated with better adherence for diabetic patients during weight loss, medications, and diet. Support from family members also shows better adherence, which necessitates for family members to ensure that they support patients, especially in avoiding stress (Delamater, A. M. 2006). Nonetheless, low-education levels and socioeconomic status as well as patients from ethnic minority status have also been shown to have low adherence to regimen. Lastly, patients with high stresses on seriousness of diabetes and associated illnesses have been seen to have more adherence related problems (Delamater, 2006).
Discussion 2
Although Assisted reproductive technology (ART) offers couples a chance to have a child and other benefits from genetic screening to surrogacy and choice of donor egg or sperm, it comes with numerous ethical issues (CDC, 2017). First, cryopreserved embryos pose a major ethical challenge. In most cases, couples fertilize numerous embryo and store them as they plan for their future families. However, once the family setup is complete, it becomes a major challenge to decide whether to dispose the rest of the embryos. Most couples leave the embryos and stop paying for their storage leaving health care organizations at a dilemma on what to do. Similarly, for cases of death or divorce, it becomes difficult to determine what to do with the embryos. The choice of donors or surrogates also poses a serious issue given that cases of exploitation or coercion have been presented. Some doctors have been reported to exploit families from poor backgrounds to become donors or surrogates without clearly explaining the associated risks. Lastly, stimulated ovulation has not been effectively examined for risks to patients, which poses a major ethical concern.
References
Centre for Disease Control and Prevention (CDC). (2017). What is Assisted Reproductive Technology? Retrirved from https://www.cdc.gov/art/whatis.html
Delamater, A. M. (2006). Improving patient adherence. Clinical Diabetes, 24(2), 71-77. https://doi.org/10.2337/diaclin.24.2.71
